Author:
Lee Kok-Onn,Tian Edmund Feng,Cai Martin Hui,Wang Hong,Chan Yiong-Huak,Sim Meng-Kwoon
Funder
National Medical Research Council, Singapore
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Sim MK. Des-aspartate-angiotensin I, a novel angiotensin AT1 receptor drug. Eur J Pharmacol. 2015;760:36-1.
2. Sim MK. The use of des-aspartate-angiotensin I in inflammation related pathologies and diseases. Patent Cooperation Treaty, International Application No. PCT/SG2011/000204, 8 Jun 2011.
3. Wang H, Sethi G, Loke WK, Sim MK. Des-aspartate-angiotensin I attenuates mortality of mice exposed to gamma radiation via a novel mechanism of action. PLoS One. 2015;10(9):e0138009.
4. Wen Q, Lee KO, Sim SZ, Xu XG, Sim MK. Des-aspartate-angiotensin I causes specific release of PGE2 and PGI2 in HUVEC via the angiotensin AT1 receptor and biased agonism. Eur J Pharmacol. 2015;768:173–81.
5. Gayes RP, Szidon JP, Opari S. In vivo and in vitro conversion of des-1-Asp angiotensin I to angiotensin III. Biochem Pharmacol. 1978;27:2871–7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献